Human Oral Tablets Prescription Only in the U.S. 3 mg & 6 mg Generic Strengths

Oral Ivermectin: Tablets and U.S. Access

Oral ivermectin is a prescription antiparasitic medicine supplied as tablets for human use in the United States. It should not be confused with ivermectin cream used for inflammatory lesions of rosacea, an over-the-counter ivermectin lotion for head lice, or veterinary preparations intended for animals. For a person comparing oral products, the starting questions are whether a tablet is an FDA-approved human medicine, which strength and manufacturer are identified on the label, and whether a clinician has prescribed that particular product. These distinctions matter before comparing brand names or pharmacy listings.

Human ivermectin tablets have FDA-labeled uses for intestinal strongyloidiasis and onchocerciasis. Prescribers may also consider oral ivermectin for some other conditions, including scabies, but an off-label use is not an additional FDA-approved indication. In the U.S., approved generic tablet products include 3 mg and 6 mg strengths. The strength printed on a package describes the amount of active ingredient per tablet; it does not tell a patient how many tablets to take or whether treatment is appropriate. Product identity and clinical decisions are separate questions.

Use this overview to understand the oral tablet category before moving to a specific product or service. Compare ivermectin 3 mg tablets and ivermectin 6 mg tablets, examine generic ivermectin products and the Stromectol brand, or explore U.S. prescription requirements. Pharmacy availability, costs, clinical suitability and dispensing requirements must be established separately rather than assumed from an FDA approval record.

What Qualifies as a Human Oral Ivermectin Tablet in the U.S.?

A human oral ivermectin product is identified by more than the active ingredient alone. The package or pharmacy record should describe tablets for oral administration, the strength in milligrams, the labeler or manufacturer, and the prescription status. FDA approval applies to specified drug products; a seller using the word ivermectin is not evidence that an unfamiliar product is approved for human use. A reference brand, an approved generic, and an unverified internet listing should not be treated as the same category merely because their names resemble each other.

Ivermectin is also an ingredient in other human formulations. Cream 1% and lotion 0.5% serve different treatment contexts and carry different U.S. access rules. A person seeking tablets should therefore avoid substituting a topical preparation or interpreting its over-the-counter status as permission to obtain oral tablets without a prescription. Likewise, products prepared for horses, cattle or other animals have different formulations and must not be used as human alternatives.

The following overview separates the main U.S. oral tablet strength categories without attempting to select a dose. More detailed product and label distinctions belong on the dedicated strength pages, while prescription and dispensing questions are addressed in separate access guides.

Human oral tablet category U.S. regulatory context What the strength tells you Related product page
Ivermectin 3 mg tablets Prescription; FDA-approved human tablet products include 3 mg generics 3 mg of ivermectin per tablet; not a patient-specific regimen 3 mg tablet products
Ivermectin 6 mg tablets Prescription; FDA-approved 6 mg generic tablet products exist 6 mg of ivermectin per tablet; approval does not establish retail stock 6 mg tablet products
Stromectol reference brand Historical U.S. reference-listed brand; product and strength marketing status require separate verification Brand name does not determine current availability or substitute for a prescription Stromectol brand overview

Ivermectin 3 mg vs 6 mg: Strength, Approval and Availability

The numbers 3 mg and 6 mg refer to the quantity of ivermectin contained in one tablet, not to the size of a prescribed course. The overall amount prescribed can depend on the diagnosis, patient characteristics and the applicable clinical guidance. Comparing strengths is useful for recognizing products in U.S. labeling and pharmacy systems, but the fact that a strength is available for dispensing does not mean it is suitable for every patient or condition.

FDA approval of a generic ivermectin 6 mg tablet strength is a meaningful product-registration fact. It does not mean the original Stromectol 6 mg branded tablet is currently marketed, nor does it establish that a nearby pharmacy, online pharmacy or wholesaler has the generic in stock. Approval status, commercial marketing and individual pharmacy inventory are separate pieces of information. A prescription written for an unavailable presentation may require the pharmacist and prescriber to clarify the appropriate fulfillment option; patients should not adjust a regimen on their own.

For readers interested in manufacturer details, product-specific labeling or the distinctions between a tablet strength and a prescribed quantity, the detailed product pages for each approved strength cover those questions separately. A tablet strength is a product characteristic; the appropriate prescribed quantity is a clinical decision.

Stromectol, Generic Ivermectin and U.S. Brand Status

Stromectol is the established reference brand for oral ivermectin in the U.S. regulatory record. Generic ivermectin tablets are approved through a process that evaluates whether a particular generic product meets applicable standards, including therapeutic equivalence where assigned. A generic package may display ivermectin and its manufacturer rather than the Stromectol name. These labeling differences are not, by themselves, evidence of a different active ingredient or inferior medicine.

Brand identity and market availability should be evaluated separately. In particular, historical labeling for Stromectol 6 mg must not be presented as proof that the original 6 mg brand product is being sold today; FDA documentation identifies that branded strength as discontinued from marketing in the United States. By contrast, FDA approval for a 6 mg generic product exists. Current availability therefore needs a product-specific pharmacy check rather than an assumption based on an older brand record.

The Stromectol versus generic ivermectin comparison addresses the brand–generic relationship in greater detail. For a broader view of generic labeling, strengths and manufacturer identity, see generic ivermectin tablets. A pharmacist can confirm the exact product being dispensed and answer questions about a substitution permitted under applicable rules.

FDA-Labeled Oral Uses and the Difference Between Approved and Off-Label Care

In the United States, human oral ivermectin tablets are FDA-labeled for intestinal, nondisseminated strongyloidiasis caused by Strongyloides stercoralis and for onchocerciasis caused by Onchocerca volvulus. These are specific parasitic worm infections, not an approval for every parasitic illness or skin condition. Diagnosis, clinical context and follow-up matter, and the presence of a product in an online pharmacy catalog does not establish that it is appropriate for an individual patient.

Oral ivermectin is also used by clinicians in certain circumstances outside its labeled indications. Scabies is a prominent example: CDC clinical guidance discusses oral ivermectin as a treatment option, while the FDA has not approved oral ivermectin tablets specifically for scabies. The distinction is important because medical use described in professional guidance is not the same as an FDA-labeled indication. For separate condition-specific explanations, see ivermectin for strongyloidiasis and ivermectin for scabies.

Ivermectin tablets are not FDA-approved to prevent or treat COVID-19. Claims about antiviral benefits or broad preventive use should not be treated as reasons to purchase the medicine. The medicine should be selected based on an appropriate clinical assessment, not a broad claim that ivermectin treats all infections.

Why Oral Ivermectin Requires a U.S. Prescription

Human oral ivermectin tablets are prescription medicines in the United States, regardless of whether the package is branded or generic and regardless of whether the stated strength is 3 mg or 6 mg. The prescription requirement is not removed by an online listing, mail delivery, an overseas seller or the existence of an OTC topical ivermectin product. An appropriate clinician must assess the clinical need and determine whether a prescription should be issued.

A clinician may need information about the suspected or confirmed infection, medication history, other health conditions and circumstances that affect treatment selection. This is distinct from deciding which manufacturer or package a pharmacy can supply. The dedicated ivermectin prescription guide covers prescription documentation and clinical assessment, while ivermectin telehealth addresses how remote consultations may fit into that process without guaranteeing that a prescription will result.

Once a valid prescription is issued, a licensed pharmacy can evaluate the order and applicable dispensing requirements. Readers looking for a step-by-step overview of legal purchasing channels should consult how to obtain ivermectin in the U.S.. The exact tablet product, prescriber instructions and dispensing pharmacy should agree before the prescription is filled.

How to Interpret an Oral Ivermectin Pharmacy Listing

A pharmacy listing can be useful when it clearly identifies the generic name, tablet strength, dosage form, manufacturer or labeler and prescription requirement. Those details help distinguish an FDA-approved oral product from a listing that merely uses a familiar drug name. A picture of a tablet box or a claim that an item is “human grade” does not substitute for verifiable product identity, regulatory status and appropriate pharmacy licensing.

An approval record and a commercial listing answer different questions. FDA approval concerns a defined drug product; commercial marketing concerns whether a manufacturer is placing it in the market; a pharmacy availability check concerns whether that pharmacy can actually fill a prescription. This distinction is particularly important for less familiar 6 mg listings and for brand names that may appear in older directories. Neither approval records nor search results should be presented as real-time stock confirmations.

For the differences between ordinary pharmacy fulfillment and internet ordering, visit U.S. ivermectin pharmacies or online ivermectin pharmacy checks. The first question when reviewing a pharmacy listing is whether it correctly identifies a legitimate human oral tablet product that matches a valid prescription.

Tablet Cost Factors, Generics and Insurance Coverage

The amount a patient pays for oral ivermectin can vary with the selected FDA-approved product, the strength and quantity prescribed, pharmacy pricing and payment method. A generic listing may differ in cost from a branded product, but brand and generic names alone do not establish a current price. A cost comparison must also distinguish the amount paid for the medicine from any separate clinician visit or pharmacy-service charge.

Insurance coverage depends on an individual plan, its drug formulary and the circumstances of the prescription. Covered status and patient cost sharing are not universal, and an off-label treatment context can introduce additional coverage questions. Readers can explore the general factors in the ivermectin price guide and the separate insurance coverage overview. Neither requires an outdated price chart or a promised discount to explain how costs are determined.

To compare a real prescription, the useful inputs are the prescribed strength, quantity, manufacturer or NDC when available, pharmacy and insurance or cash-payment terms. A current pharmacy quote is more reliable than a generic price claim in a search result. A current quote for the exact prescribed product is more useful than an advertised average or a price for a different strength.

Safety, Interactions and Avoiding Veterinary Ivermectin

Ivermectin tablets can cause adverse effects and may interact with other medicines. The safety considerations depend on the patient and the clinical situation; common product descriptions are not substitutes for the complete prescribing information. Patients should disclose current medicines and relevant health conditions to the prescriber and pharmacist. For a broader explanation of adverse effects, cautions and potentially important interactions, see ivermectin safety.

Veterinary ivermectin is not a substitute for FDA-approved human oral tablets. Animal pastes, injectable solutions, pour-on products and other veterinary preparations may have different concentrations, inactive ingredients and intended routes of administration. A human prescription cannot be filled by converting an animal product into a tablet equivalent at home, and taking large or inappropriate amounts of ivermectin can cause serious harm.

The existence of a 6 mg tablet, a generic approval or a clinician-directed off-label use is not a reason to select a dose without medical oversight. Clinical decisions, follow-up and questions about potential interactions require individual evaluation. This article does not provide treatment regimens, pharmacy stock guarantees or a recommendation that everyone with a suspected parasitic condition needs oral ivermectin.

Oral Tablets Are Not Interchangeable With Ivermectin Cream or Lotion

Sharing the active ingredient does not make the different ivermectin formulations interchangeable. Oral tablets are prescription antiparasitic medicines for specified systemic treatment contexts. Ivermectin cream 1% is a prescription dermatologic product labeled for inflammatory lesions of rosacea, and ivermectin lotion 0.5% is an over-the-counter head-lice product. Route of administration, concentration, product labeling and access status all matter when comparing these medicines.

Readers who intended to research a skin or scalp medicine should start with topical ivermectin or the focused oral versus topical ivermectin comparison. That separation prevents an oral tablet guide from being mistaken for instructions to use the same medicine for every condition or to replace one formulation with another.

Frequently Asked Questions

No. FDA-approved human oral ivermectin tablets are prescription medicines in the United States. An over-the-counter ivermectin lotion used for head lice does not make oral tablets OTC. A pharmacy should dispense prescription tablets only with a valid prescription under applicable law.

FDA-approved generic ivermectin tablet products include 3 mg and 6 mg strengths. The strength is the amount of ivermectin in one tablet, not a recommendation for the number of tablets someone should take. The prescriber determines the appropriate product and regimen.

No. Regulatory approval, commercial marketing and an individual pharmacy’s inventory are different matters. An approved 6 mg generic product may not be stocked by every pharmacy, and a historical branded 6 mg product should not be assumed to be currently marketed. Availability requires a separate pharmacy check.

In the United States, oral ivermectin tablets are FDA-labeled for intestinal, nondisseminated strongyloidiasis and onchocerciasis. These are specific parasitic infections. A clinician determines whether ivermectin is appropriate after evaluating the diagnosis and other relevant patient factors.

No. Oral ivermectin tablets are not FDA-approved specifically for scabies, although CDC clinical guidance discusses oral ivermectin as an option in some scabies treatment situations. This is an off-label context that requires a clinician’s judgment; it does not create an over-the-counter indication or justify self-treatment.

Stromectol is the reference brand associated with oral ivermectin, while approved generics are marketed under the generic name and their manufacturers’ labels. FDA therapeutic-equivalence determinations apply to defined products. Brand status and current pharmacy availability should still be checked separately rather than inferred from the name alone.

No. Cream and lice lotion have different routes of administration, concentrations and labeled purposes. Veterinary ivermectin is formulated for animals and may differ substantially from products intended for people. Human oral tablets should not be substituted with any of those preparations.

A licensed clinician may evaluate a patient through an appropriate telehealth service, subject to applicable rules and clinical standards. Whether a prescription is issued depends on the assessment; a remote appointment does not guarantee treatment. A legitimate pharmacy still requires a valid prescription to dispense oral tablets.

No. FDA has not approved or authorized ivermectin for prevention or treatment of COVID-19. FDA-approved human oral ivermectin products are intended for their specified parasitic indications, and claims about treating COVID-19 should not be used to justify obtaining the drug.